700
A. B. Atar et al.
J = 2.2 Hz, 9.2 Hz, 1H), 4.45–4.42 (m, 2H), 2.97 (s, 3H),
1.45 (t, J = 8.0 Hz, 3H) ppm; 13C NMR (100 MHz,
CDCl3): d = 167.23, 159.83, 147.99, 139.78, 133.45,
133.23, 131.26, 127.96, 127.40, 125.88, 62.62, 26.66,
15.34 ppm; HRMS (ESI): m/z calcd for C13H12ClNO2
249.0557, found 249.0559.
2-Chloro-5,6,7,8-tetrahydroacridine (3l, C13H12ClN)
1
Rf = 0.27 (hexane/ethyl acetate 7:3); m.p.: 86–87 °C; H
NMR (400 MHz, CDCl3): d = 7.88 (d, J = 9.2 Hz, 1H),
7.64 (d, J = 12.1 Hz, 2H), 7.51 (dd, J = 2.0 Hz, 9.0 Hz,
1H), 3.09 (t, J = 6.6 Hz, 2H), 2.94 (t, J = 6.2 Hz, 2H),
1.99–1.95 (m, 2H), 1.89–1.85 (m, 2H) ppm; 13C NMR
(100 MHz, CDCl3): d = 160.74, 145.94, 134.94, 133.04,
132.06, 130.94, 130.34, 128.76, 126.49, 34.52, 30.26,
24.10, 23.77 ppm; HRMS (ESI): m/z calcd for C13H12ClN
217.0658, found 217.0656.
Methyl 6-chloro-2-methylquinoline-3-carboxylate
(3h, C12H10ClNO2)
Rf = 0.25 (hexane/ethyl acetate 7:3); m.p.: 138–139 °C;
1H NMR (400 MHz, CDCl3): d = 8.63 (s, 1H), 7.96 (d,
J = 8.0 Hz, 1H), 7.82 (d, J = 4.0 Hz, 1H), 7.70 (dd,
J = 4.0 Hz, 8.0 Hz, 1H), 3.98 (s, 3H), 2.97 (s, 3H) ppm;
13C NMR (100 MHz, CDCl3): d = 167.62, 159.87, 148.06,
139.94, 133.56, 133.29, 131.28, 127.98, 127.37, 125.47,
53.54, 26.66 ppm; HRMS (ESI): m/z calcd for C12H10
ClNO2 235.04, found 235.04.
t-Butyl 6-chloro-2-methylquinoline-3-carboxylate
(3m, C15H16ClNO2)
1
Rf = 0.28 (hexane/ethyl acetate 7:3); m.p.: 98–99 °C; H
NMR (400 MHz, CDCl3): d = 8.51 (s, 1H), 7.95 (d,
J = 9.2 Hz, 1H), 7.83 (d, J = 2.0 Hz, 1H), 7.68 (dd,
J = 2.4 Hz, 8.9 Hz, 1H), 2.94 (s, 3H), 1.65 (s, 9H) ppm;
13C NMR (100 MHz, CDCl3): d = 166.71, 159.50, 147.75,
139.31, 133.15, 133.09, 131.18, 127.89, 127.70, 127.51,
83.49, 29.28, 26.70 ppm; HRMS (ESI): m/z calcd for
C15H16ClNO2 277.0807, found 277.0809.
Benzyl 6-chloro-2-methylquinoline-3-carboxylate
(3i, C18H14ClNO2)
1
Rf = 0.28 (hexane/ethyl acetate 7:3); m.p.: 96–97 °C; H
NMR (400 MHz, CDCl3): d = 8.63 (s, 1H), 7.94 (d,
J = 9.2 Hz, 1H), 7.79 (d, J = 2.2 Hz, 1H), 7.67 (dd,
J = 2.2 Hz, 8.8 Hz, 1H), 7.49–7.35 (m, 5H), 5.41 (s, 2H),
2.96 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3): d =
166.95, 159.92, 140.01, 136.57, 133.60, 133.28, 131.27,
129.82, 129.65, 129.56, 128.02, 127.35, 125.44, 68.42,
26.75 ppm; HRMS (ESI): m/z calcd for C18H14ClNO2
311.0713, found 311.0710.
Ethyl 6-chloro-2-(trifluoromethyl)quinoline-3-carboxylate
(3n, C13H9ClF3NO2)
1
Rf = 0.28 (hexane/ethyl acetate 7:3); m.p.: 99–100 °C; H
NMR (400 MHz, CDCl3): d = 8.59 (s, 1H), 8.19 (d,
J = 9.2 Hz, 1H), 7.95 (d, J = 2.2 Hz, 1H), 7.83 (dd,
J = 2.2 Hz, 9.2 Hz, 1H), 4.51–4.45 (m, 2H), 1.44 (t,
J = 7.2 Hz, 3H) ppm; 13C NMR (100 MHz, CDCl3):
d = 166.22, 146.29, 140.08, 134.44, 132.73, 129.88,
128.44, 127.78, 63.74, 14.98 ppm; HRMS (ESI): m/z calcd
for C13H9ClF3NO2 303.0274, found 303.0275.
Ethyl 6-chloro-2-(chloromethyl)quinoline-3-carboxylate
(3j, C13H11Cl2NO2)
Rf = 0.27 (hexane/ethyl acetate 7:3); m.p.: 122–123 °C;
1H NMR (400 MHz, CDCl3): d = 8.71 (s, 1H), 8.05 (d,
J = 8.8 Hz, 1H), 7.89 (d, J = 2.2 Hz, 1H), 7.75 (dd,
J = 2.2 Hz, 9.2 Hz, 1H), 5.24 (s, 2H), 4.52–4.46 (m, 2H),
1.47 (t, J = 7.1 Hz, 3H) ppm; 13C NMR (100 MHz,
CDCl3): d = 166.34, 156.97, 147.65, 140.83, 134.78,
133.94, 131.95, 128.29, 128.00, 125.15, 63.11, 47.39,
15.20 ppm; HRMS (ESI): m/z calcd for C13H11Cl2NO2
283.0167, found 283.0169.
Isopropyl 6-chloro-2-methylquinoline-3-carboxylate
(3o, C14H14ClNO2)
1
Rf = 0.27 (hexane/ethyl acetate 7:3); m.p.: 96–97 °C; H
NMR (400 MHz, CDCl3): d = 8.58 (s, 1H), 7.95 (d,
J = 9.2 Hz, 1H), 7.83 (d, J = 2.2 Hz, 1H), 7.68 (dd,
J = 2.4 Hz, 8.3 Hz, 1H), 5.34–5.24 (m, 1H), 2.96 (s, 3H),
1.43 (d, J = 6.2 Hz, 4H) ppm; 13C NMR (100 MHz,
CDCl3): d = 166.82, 159.71, 147.89, 139.58, 133.33,
133.16, 131.20, 127.93, 127.41, 126.37, 70.32, 26.66,
22.98 ppm; HRMS (ESI): m/z calcd for C14H14ClNO2
263.0713, found 263.0711.
7-Chloro-3,4-dihydro-3,3-dimethylacridin-1(2H)-one
(3k, C15H14ClNO)
Rf = 0.29 (hexane/ethyl acetate 7:3); m.p.: 152–153 °C;
1H NMR (400 MHz, CDCl3): d = 8.72 (s, 1H), 7.98 (d,
J = 8.8 Hz, 1H), 7.90 (d, J = 2.2 Hz, 1H), 7.72 (dd,
J = 2.2 Hz, 8.8 Hz, 1H), 3.18 (s, 2H), 2.66 (s, 2H), 1.15 (s,
6H) ppm; 13C NMR (100 MHz, CDCl3): d = 198.61,
162.12, 149.35, 136.48, 132.95, 134.01, 131.26, 129.07,
128.38, 126.89, 53.45, 48.14, 33.76, 29.39 ppm; HRMS
(ESI): m/z calcd for C15H14ClNO 259.0764, found
259.0766.
Ethyl 6-chloro-2-propylquinoline-3-carboxylate
(3p, C15H16ClNO2)
1
Rf = 0.28 (hexane/ethyl acetate 7:3); m.p.: 72–73 °C; H
NMR (400 MHz, CDCl3): d = 8.57 (s, 1H), 7.98 (d,
J = 9.2 Hz 1H), 7.82 (d, J = 2.0 Hz, 1H), 7.69 (dd,
J = 2.2 Hz, 9.1 Hz, 1H), 4.47–4.41 (m, 2H), 3.27 (t,
J = 7.9 Hz, 2H), 1.85-1.75 (m, 2H), 1.45 (t, J = 7.0 Hz,
3H), 1.04 (t, J = 7.0 Hz, 3H) ppm; 13C NMR (100 MHz,
123